E-mail a Wiley Online Library Link

M. van Zonneveld, H. J. Flink, E. Verhey, H. Senturk, S. Zeuzem, U. S. Akarca, Y. Cakaloglu, C. Simon, T. M. K. So, G. Gerken, R. A. de Man, B. E. Hansen, S. W. Schalm, H. L. A. Janssen and The HBV 99-01 Study Group The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation Alimentary Pharmacology & Therapeutics 21

Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02453.x

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field